Yes, the quiet period referenced was evoked by the filing of the http://www.sec.gov/Archives/edgar/data/1355250/000154823313000003/S3-1-18-2012.htm S-3 registration on 1-18-13 until the http://www.sec.gov/Archives/edgar/data/1355250/999999999513000525/xslEFFECTX01/primary_doc.xml Notice of Effectiveness on 2-15-13 Do you are does anyone else know why they were under a quite period? Could it be for uplisting possibly? Was it self-imposed? http://cellceutix.com/cellceutix-reports-on-kevetrin-clinical-trials-and-prurisol-manufacturing/ The Company is pleased to report that the recently filed registration statement with the Security and Exchange Commission is now effective, thus concluding the imposed “quiet period”. .